Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

US Pneumonia Treatment Report 2017 - Research and Markets

Research and Markets
Posted on: 30 Aug 17

The "Pneumonia - Treatment Report" report has been added to Research and Markets' offering.

Informed by real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals across the US, this report estimates 30% of all hospital discharges involve treatment of infectious organisms.

Pneumonia is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for around $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of pneumonia patient characteristics, medication management, costs, and laboratory testing.

Gram-negative bacteria are the likely causative agents of most pneumonia infections and physicians treat most of these patients with levofloxacin, ceftriaxone, and azithromycin. This report provides quantitative, objective data focused on the treatment of pneumonia requiring hospitalization captured by hospitals contributing to Cerner Health Facts. This data provides real-world patient encounters and reflects real physician decisions and encounter characteristics (e.g. patient response to therapy and outcomes) in key areas, such as antimicrobial stewardship.

Key Topics Covered:

1. Patient Flow

2. Executive Summary

3. Incidence and Impact of Disease

  • Incidence
  • Length of Stay
  • Total Cost

4. Patient Demographics

  • Age
  • Insurance type
  • Gender
  • Region
  • Mortality
  • Comorbid Conditions

5. Patient Flow through the Hospital

  • Admission Site
  • Lab Testing
  • Lab TAT
  • Results
  • Etiology
  • Empiric Therapy
  • Change in treatment

6. Drug Share for Key Therapeutics

  • Most Common
  • LOS
  • APACHE Score
  • Treatment Duration
  • Product Dashboards
    • Market Share
    • Demographics
    • Hospitalization

7. Outcomes of Treatment

  • Antibiotic Usage
  • Mortality
  • Cost per Patient

8. Database Overview

9. Methodology

For more information about this report visit https://www.researchandmarkets.com/research/pwsxjc/pneumonia

View source version on businesswire.com: http://www.businesswire.com/news/home/20170830005961/en/

Business Wire
www.businesswire.com

Last updated on: 30/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.